Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Neumora Therapeutics Inc (NASDAQ: NMRA) closed at $972.29K up 870497% from its previous closing price of $0.78. In other words, the price has increased by $870497 from its previous closing price. On the day, 0.87 million shares were traded. NMRA stock price reached its highest trading level at $0.8087 during the session, while it also had its lowest trading level at $0.7611.
Ratios:
For a deeper understanding of Neumora Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.98 and its Current Ratio is at 8.98. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Stifel Downgraded its Buy to Hold on March 07, 2025, whereas the target price for the stock was revised from $6 to $2.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 12 ’25 when Henry Gosebruch bought 15,000 shares for $1.43 per share.
BERNS PAUL L sold 13,871 shares of NMRA for $23,468 on Feb 18 ’25. The insider now owns 7,405,004 shares after completing the transaction at $1.69 per share. On Feb 18 ’25, another insider, Milligan Michael Lee, who serves as the insider of the company, sold 1,978 shares for $1.69 each. As a result, the insider received 3,351 and left with 22,470 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMRA now has a Market Capitalization of 127085408 and an Enterprise Value of -121329656.
Stock Price History:
The Beta on a monthly basis for NMRA is 2.69, which has changed by -0.91726315 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, NMRA has reached a high of $17.19, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 5.03%, while the 200-Day Moving Average is calculated to be -86.36%.
Shares Statistics:
For the past three months, NMRA has traded an average of 972.29K shares per day and 1093470 over the past ten days. A total of 161.75M shares are outstanding, with a floating share count of 65.21M. Insiders hold about 59.69% of the company’s shares, while institutions hold 28.38% stake in the company. Shares short for NMRA as of 1748563200 were 15021286 with a Short Ratio of 15.45, compared to 1745971200 on 12784957. Therefore, it implies a Short% of Shares Outstanding of 15021286 and a Short% of Float of 25.66.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Its stock is currently analyzed by 6.0 different market analysts. The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.3 and low estimates of -$0.46.
Analysts are recommending an EPS of between -$0.86 and -$1.79 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$1.12, with 7.0 analysts recommending between -$0.36 and -$1.77.
